Clonazepam and Cyclobenzaprine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clonazepam and Cyclobenzaprine hydrochloride. Common interactions include tremor among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people who take Clonazepam and Cyclobenzaprine hydrochloride have. It is created by eHealthMe based on reports of 312 people who take Clonazepam and Cyclobenzaprine hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 06, 2022

312 people who take Clonazepam and Cyclobenzaprine hydrochloride together, and have interactions are studied.


What is Clonazepam?

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. eHealthMe is studying from 128,287 Clonazepam users for its effectiveness, alternative drugs and more.

What is Cyclobenzaprine hydrochloride?

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 6,539 Cyclobenzaprine hydrochloride users for its effectiveness, alternative drugs and more.

Number of Clonazepam and Cyclobenzaprine hydrochloride reports submitted per year:

Clonazepam and Cyclobenzaprine hydrochloride drug interactions.

Clonazepam and Cyclobenzaprine hydrochloride drug interactions by gender *:

Click here to view

Clonazepam and Cyclobenzaprine hydrochloride drug interactions by age *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Clonazepam and Cyclobenzaprine hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Clonazepam and Cyclobenzaprine hydrochloride interactions:

Browse all drug interactions of Clonazepam and Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clonazepam side effects:

Browse all side effects of Clonazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cyclobenzaprine hydrochloride side effects:

Browse all side effects of Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clonazepam interactions:

Browse all interactions between Clonazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cyclobenzaprine hydrochloride interactions:

Browse all interactions between Cyclobenzaprine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clonazepam and cyclobenzaprine hydrochloride (the active ingredients of Clonazepam and Cyclobenzaprine hydrochloride, respectively), and Clonazepam and Cyclobenzaprine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Clonazepam and Cyclobenzaprine hydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: